Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease

Increasing evidence suggests that rapid eye movement sleep behaviour disorder (RBD) is a heralding feature associated with evolving α-synucleinopathy-related neurodegenerative disorders.1–4 Several neurobiological markers such as olfactory abnormality were associated with the development of neurodegenerative disorders in ‘idiopathic’ RBD (iRBD) patients.5 On the other hand, pre-morbid psychiatric disorders were suggested as an important but often neglected preclinical marker of Parkinson's disease (PD),6 and its role is unclear in iRBD patients. The current study aimed to provide a quantitative risk estimate of neurodegenerative outcome, and to investigate the role of psychiatric disorders in predicting future neurodegenerative disorders in a prospective cohort of Hong Kong Chinese iRBD patients. Ninety-one iRBD patients (82.4% men) (recruited during 1994–2009) were prospectively followed-up with routine clinical assessments in our sleep centre for a mean duration of 5.6 years (SD 3.3).1 An additional research-based follow-up protocol has been implemented since 2008, which included neuropsychiatric examinations as conducted by the research …

[1]  V. Mok,et al.  REM sleep behavior disorder in psychiatric populations. , 2010, The Journal of clinical psychiatry.

[2]  J. Finsterer,et al.  Presentation, Etiology, Diagnosis, and Management of Camptocormia , 2010, European Neurology.

[3]  R. Postuma,et al.  Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. , 2009, Brain : a journal of neurology.

[4]  M. Vendette,et al.  Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder , 2009, Neurology.

[5]  Y. Wing,et al.  REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[6]  Y. Wing,et al.  Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. , 2008, The Journal of clinical psychiatry.

[7]  José Luis Molinuevo,et al.  Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study , 2006, The Lancet Neurology.

[8]  Nora Turjanski,et al.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. , 2005, Brain : a journal of neurology.

[9]  D B Sanders,et al.  Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. , 2000, Neurology.

[10]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[11]  J. Cummings,et al.  Depression and Parkinson's disease: a review. , 1992, The American journal of psychiatry.

[12]  T. Kurihara,et al.  Myasthenia gravis with concomitant severe paraspinal muscle degeneration and mitochondrial DNA4977 deletion. , 2007, Internal medicine.